Related Experiment Video
Updated: Aug 5, 2026

06:15
A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
The Application of Injectable Hydrogels in Myocardial Infarction Repair: Material Design, Biological Functions and
Zhichao Zhang1,2, Xinyue Lang1,2, Yunlong Zhang1
1Central Hospital of Dalian University of Technology, Dalian 116089, China.
International Journal of Molecular Sciences
|July 28, 2026
Summary
Injectable hydrogels offer a promising strategy for repairing hearts after myocardial infarction (heart attack). These advanced materials support cardiac tissue and deliver therapies, improving recovery and regeneration.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Regenerative Medicine
Background:
- Myocardial infarction (MI) causes significant heart damage through inflammation, cell loss, and poor vascularization.
- Current treatments for MI have limitations in addressing the complex pathological cascade.
- Injectable hydrogels present a minimally invasive approach for cardiac repair.
Purpose of the Study:
- To review pathology-informed design principles for injectable hydrogels in myocardial infarction repair.
- To discuss hydrogel strategies for modulating the cardiac microenvironment and promoting regeneration.
- To examine translational progress and challenges for clinical application.
Main Methods:
- Literature review of injectable hydrogel design and application in myocardial infarction.
- Analysis of hydrogel properties relevant to cardiac tissue repair (e.g., injectability, adhesion, biodegradability).
- Discussion of hydrogel-mediated therapeutic strategies (immunomodulation, angiogenesis, regeneration).
Main Results:
- Key hydrogel design principles include shear-thinning injectability, in situ gelation, tissue adhesion, modulus matching, fatigue resistance, biodegradability, and controlled bioactivity.
- Hydrogels can be engineered for immunomodulation, enhanced angiogenesis, fibrosis reduction, ECM remodeling, and myocardial regeneration.
- Translational progress is notable, but challenges in biosafety, manufacturing, standardization, and long-term efficacy remain.
Conclusions:
- Injectable hydrogels provide a versatile platform for addressing multiple pathologies post-myocardial infarction.
- Optimized hydrogel design and therapeutic delivery are crucial for effective cardiac repair and regeneration.
- Overcoming translational hurdles is essential for the clinical success of hydrogel-based therapies for MI.

